Long-term ursodeoxycholate improves circulating redox changes in primary biliary cirrhotic patients

Clinical Biochemistry

Volumn 44, Issue 17-18, 2011, Pages 1400-1404

  Grattagliano, Ignazio ^a   Palmieri, Vincenzo O ^a   Portincasa, Piero ^a   Minerva, Francesco ^a   Palasciano, Giuseppe ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

Glutathione; Nitric oxide; Nitrosothiols, nitrotyrosine; Primary biliary cirrhosis; Protein sulfhydryls; Protein glutathione mixed disulfides; Thioredoxin; Ursodeoxycholate

Indexed keywords

3 NITROTYROSINE; ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BILE ACID CONJUGATE; THIOREDOXIN; URSODEOXYCHOLIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CIRCULATION; CLINICAL ARTICLE; CONJUGATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FATIGUE; FEMALE; HISTOPATHOLOGY; HUMAN; HYDROPHILICITY; LONG TERM CARE; NITROSATIVE STRESS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTECTION; PRURITUS;

ADULT; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLAGOGUES AND CHOLERETICS; FEMALE; HUMANS; KERATIN-18; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; NITROSO COMPOUNDS; OXIDATION-REDUCTION; OXIDATIVE STRESS; THIOREDOXINS; TYROSINE; URSODEOXYCHOLIC ACID;

EID: 81555219192     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.09.008     Document Type: Article

References (39)

1. Grattagliano I., Portincasa P., Palmieri V.O., Palasciano G. Mutual changes of thioredoxin and nitrosothiols during biliary cirrhosis: results from humans and cholestatic rats. Hepatology 2007, 45:331-339.
2. Krahenbuhl S., Talos C., Lauterburg B.H., Reichen J. Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats. Hepatology 1995, 22:607-612.
3. Vendemiale G., Grattagliano I., Lupo L., Memeo V., Altomare E. Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage. J Hepatol 2002, 37:601-605.
4. Grattagliano I., Giudetti A.M., Grattagliano V., Palmieri V.O., Gnoni G.V., Lapadula G., et al. Structural and oxidative modifications of erythrocyte ghosts in patients with primary biliary cirrhosis: relation with the disease stage and effect of bile acid treatment. Eur J Clin Invest 2003, 33:868-874.
5. Grattagliano I., Russmann S., Palmieri V.O., Portincasa P., Palasciano G., Lauterburg B.H. Glutathione peroxidase, thioredoxin, and membrane protein changes in erythrocytes predict ribavirin-induced anemia. Clin Pharmacol Ther 2005, 78:422-432.
6. Arriero M.M., Lopez-Farre A., Fryeiro O., Rodriguez-Feo J.A., Velasco S., Garcia-Duran M., et al. Expression of inducible nitric oxide synthase in the liver of bile duct-ligated Wistar rats with modulation by lymphomononuclear cells. Surgery 2001, 129:255-266.
7. McNaughton L., Puttagunta L., Martinez-Cuesta M.A., Kneteman N., Mayers I., Moqbel R., et al. Distribution of nitric oxide synthase in normal and cirrhotic human liver. Proc Natl Acad Sci U S A 2002, 99:17161-17166.
8. Hokari A., Zeniya M., Esumi H., Kawabe T., Gershwin M.E., Toda G. Detection of serum nitrite and nitrate in primary biliary cirrhosis: possible role of nitric oxide in bile duct injury. J Gastroenterol Hepatol 2002, 17:308-315.
9. Ottesen L.H., Harry D., Frost M., Davies S., Khan K., Halliwell B., et al. Increased formation of S-nitrothiols and nitrotyrosine in cirrhotic rats during endotoxemia. Free Radic Biol Med 2001, 31:790-798.
10. Sanz-Cameno P., Medina J., Garcia-Buey L., Garcia-Sanchez A., Borque M.J., Martin-Vilchez S., et al. Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis. J Hepatol 2002, 37:723-729.
11. Wu C.T., Eiserich J.P., Ansari A.A., Coppel R.L., Balasubramanian S., Bowlus C.L., et al. Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions. Hepatology 2003, 38:1018-1025.
12. Zipprich A., Loureiro-Silva M.R., Jain D., D'Silva I., Groszmann R.J. Nitric oxide and vascular remodeling modulate hepatic arterial vascular resistance in the isolated perfused cirrhotic rat liver. J Hepatol 2008, 49:739-745.
13. Nakamura H. Thioredoxin and its related molecules: update 2005. Antioxid Redox Signal 2005, 7:823-828.
14. Nordberg J., Arner E.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 2001, 31:1287-1312.
15. Nikitovic D., Holmgren A. S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide. J Biol Chem 1996, 271:19180-19185.
16. Stoyanovsky D.A., Tyurina Y.Y., Tyurin V.A., Anand D., Mandavia D.N., Gius D., et al. Thioredoxin and lipoic acid catalyze the denitrosation of low molecular weight and protein S-nitrosothiols. J Am Chem Soc 2005, 127:15815-15823.
17. Grattagliano I., Portincasa P., Cocco T., Moschetta A., Di Paola M., Palmieri V.O., et al. Effect of dietary restriction and N-acetylcysteine supplementation on intestinal mucosa and liver mitochondrial redox status and function in aged rats. Exp Gerontol 2004, 39:1323-1332.
18. Arnelle D.R., Stamler J.S. NO+, NO, and NO- donation by S-nitrosothiols: implications for regulation of physiological functions by S-nitrosylation and acceleration of disulfide formation. Arch Biochem Biophys 1995, 318:279-285.
19. Stamler J.S. S-nitrosothiols and the bioregulatory actions of nitrogen oxides through reactions with thiol groups. Curr Top Microbiol Immunol 1995, 196:19-36.
20. Stamler J.S., Simon D.I., Osborne J.A., Mullins M.E., Jaraki O., Michel T., et al. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci U S A 1992, 89:444-448.
21. Albillos A., Rossi I., Cacho G., Martinez M.V., Millan I., Abreu L., et al. Enhanced endothelium-dependent vasodilation in patients with cirrhosis. Am J Physiol 1995, 268:G459-G464.
22. Yagmur E., Trautwein C., Leers M.P., Gressner A.M., Tacke F. Elevated apoptosis-associated cytokeratin 18 fragments [CK18Asp386] in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation. Clin Biochem 2007, 40:651-655.
23. Poupon R.E., Lindor K.D., Pares A., Chazouilleres O., Poupon R., Heathcote E.J. Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis. J Hepatol 2003, 39:12-16.
24. Lapenna D., Ciofani G., Festi D., Neri M., Pierdomenico S.D., Giamberardino M.A., et al. Antioxidant properties of ursodeoxycholic acid. Biochem Pharmacol 2002, 64:1661-1667.
25. Scheuer P. Primary biliary cirrhosis. Proc R Soc Med 1967, 60:1257-1260.
26. Cook J.A., Kim S.Y., Teague D., Krishna M.C., Pacelli R., Mitchell J.B., et al. Convenient colorimetric and fluorometric assays for S-nitrosothiols. Anal Biochem 1996, 238:150-158.
27. Yang W., Benjamin I.S., Moore K., Portmann B., Alexander B. The action of nitric oxide on hepatic haemodynamics during secondary biliary cirrhosis in the rat. Eur J Pharmacol 2003, 461:41-48.
28. Zhong B., Strnad P., Selmi C., Invernizzi P., Tao G.Z., Caleffi A., et al. Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity. Hepatology 2009, 50:546-554.
29. Jorgensen R., Angulo P., Dickson E.R., Lindor K.D. Results of long-term ursodiol treatment for patients with primary biliary cirrhosis. Am J Gastroenterol 2002, 97:2647-2650.
30. Gong Y., Huang Z.B., Christensen E., Gluud C. Ursodeoxycholic acid for primary biliary cirrhosis. Cochrane Database Syst Rev 2008, 3:CD000551.
31. Goulis J., Leandro G., Burroughs A.K. Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet 1999, 354:1053-1060.
32. Mani A.R., Ebrahimkhani M.R., Ippolito S., Ollosson R., Moore K.P. Metalloprotein-dependent decomposition of S-nitrosothiols: studies on the stabilization and measurement of S-nitrosothiols in tissues. Free Radic Biol Med 2006, 40:1654-1663.
33. Mathews W.R., Kerr S.W. Biological activity of S-nitrosothiols: the role of nitric oxide. J Pharmacol Exp Ther 1993, 267:1529-1537.
34. Zhou J., Eleni C., Spyrou G., Brune B. The mitochondrial thioredoxin system regulates nitric oxide-induced HIF-1alpha protein. Free Radic Biol Med 2008, 44:91-98.
35. Damdimopoulos A.E., Miranda-Vizuete A., Pelto-Huikko M., Gustafsson J.A., Spyrou G. Human mitochondrial thioredoxin. Involvement in mitochondrial membrane potential and cell death. J Biol Chem 2002, 277:33249-33257.
36. Moon K.H., Hood B.L., Mukhopadhyay P., Rajesh M., Abdelmegeed M.A., Kwon Y.I., et al. Oxidative inactivation of key mitochondrial proteins leads to dysfunction and injury in hepatic ischemia reperfusion. Gastroenterology 2008, 135:1344-1357.
37. Okada K., Shoda J., Taguchi K., Maher J.M., Ishizaki K., Inoue Y., et al. Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. Am J Physiol Gastrointest Liver Physiol 2008, 295:G735-G747.
38. Arisawa S., Ishida K., Kameyama N., Ueyama J., Hattori A., Tatsumi Y., et al. Ursodeoxycholic acid induces glutathione synthesis through activation of PI3K/Akt pathway in HepG2 cells. Biochem Pharmacol 2009, 77:858-866.
39. Kim Y.C., Masutani H., Yamaguchi Y., Itoh K., Yamamoto M., Yodoi J. Hemin-induced activation of the thioredoxin gene by Nrf2. A differential regulation of the antioxidant responsive element by a switch of its binding factors. J Biol Chem 2001, 276:18399-18406.